- Home
- MNMD vs THR Comparison
MNMD vs THR Comparison
Compare MNMD & THR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNMD
- THR
- Stock Information
- Founded
- MNMD 2019
- THR 1954
- Country
- MNMD United States
- THR United States
- Employees
- MNMD N/A
- THR N/A
- Industry
- MNMD Pharmaceuticals and Biotechnology
- THR Industrial Machinery/Components
- Sector
- MNMD Health Care
- THR Energy
- Exchange
- MNMD Nasdaq
- THR Nasdaq
- Market Cap
- MNMD 960.2M
- THR 879.5M
- IPO Year
- MNMD N/A
- THR 2011
- Fundamental
- Price
- MNMD $13.39
- THR $27.89
- Analyst Decision
- MNMD Strong Buy
- THR
- Analyst Count
- MNMD 7
- THR 0
- Target Price
- MNMD $26.71
- THR N/A
- AVG Volume (30 Days)
- MNMD 1.8M
- THR 153.4K
- Earning Date
- MNMD 10-31-2025
- THR 11-06-2025
- Dividend Yield
- MNMD N/A
- THR N/A
- EPS Growth
- MNMD N/A
- THR 9.96
- EPS
- MNMD N/A
- THR 1.58
- Revenue
- MNMD N/A
- THR $491,979,000.00
- Revenue This Year
- MNMD N/A
- THR $2.56
- Revenue Next Year
- MNMD N/A
- THR $6.31
- P/E Ratio
- MNMD N/A
- THR $17.63
- Revenue Growth
- MNMD N/A
- THR N/A
- 52 Week Low
- MNMD $4.70
- THR $23.05
- 52 Week High
- MNMD $14.30
- THR $33.25
- Technical
- Relative Strength Index (RSI)
- MNMD 60.21
- THR 50.70
- Support Level
- MNMD $12.41
- THR $27.20
- Resistance Level
- MNMD $13.74
- THR $28.94
- Average True Range (ATR)
- MNMD 0.84
- THR 0.86
- MACD
- MNMD -0.06
- THR 0.07
- Stochastic Oscillator
- MNMD 52.55
- THR 54.86
About MNMD Mind Medicine (MindMed) Inc.
Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).
About THR Thermon Group Holdings Inc.
Thermon Group Holdings Inc is a United States-based company that provides engineered industrial process heating solutions for process industries. It offers a full suite of products (heating units, electrode and gas-fired boilers, heating cables, industrial heating blankets and related products, temporary power solutions and tubing bundles), services (engineering, installation and maintenance services) and software (design optimization and wireless and network control systems) required to deliver comprehensive solutions to some of the world's Large and most complex projects. Its products and services include a wide range of electric heat tracing cables, steam heating solutions, controls, monitoring and software, instrumentation, project services, industrial heating and filtration solutions.